Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03235271 · ClinicalTrials.gov registry record
Pilot Study of Acute Stroke Using the Brainpulse™
A clinical trial of Stroke, Acute, sponsored by Jan Medical.
- Completed
- Registry status
- 252
- Enrollment target
- 3
- Study locations
NCT03235271: Completed study of Stroke, Acute, sponsored by Jan Medical.
NCT03235271 is a study of Stroke, Acute that has completed, run by Jan Medical. The registered enrollment target is 252 participants, below the 620-participant average among 25 other Stroke, Acute trials with a reported enrollment target (59% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03235271, a study of Stroke, Acute, has completed, sponsored by Jan Medical.
- COMPLETED
- Registry status
- 252 participants
- Enrollment target
- 3
- Study locations
Study Summary
The aim of this pilot study is to collect data on stroke patients and non-stroke patients or healthy volunteers using the BrainPulse Stroke Monitor. Subject characteristics, diagnostic procedures and clinical outcomes will be documented as part of the data collected to assess the clinical utility of the BrainPulse device. All eligible patients and healthy volunteers will be enrolled and assigned to a study Group based on confirmation of their diagnosis: Acute Ischemic Stroke, Hemorrhagic Stroke, Transient Ischemic Attack or No Stroke. The data collected from the BrainPulse will be compared across the different study groups in an attempt to distinguish stroke from other non-stroke conditions that present with similar symptoms and LVO from non-LVO types of strokes. Further assessments will also be made to evaluate if the BrainPulse can identify the presence of stroke.
Primary Outcome
The primary endpoint in Part I of the study is to enroll and record BrainPulse data from 35 eligible subjects who present with classic stroke symptoms and either have a confirmed diagnosis of stroke or no stroke. The BrainPulse device will be used to analyze and compare the differences in signal characteristics between stroke, TIA and control subjects.
Conditions Studied
Interventions
- DEVICE BrainPulse Device
Study Locations (3)
Illinois
- Northwest Community Healthcare - Arlington Heights
- NorthShore University Health System - Evanston
Ohio
- University of Cincinnati, Department of Emergency Medicine - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2017-09-10 |
| Est. Completion | 2024-08-28 |
What the finished NCT03235271 record still lists
NCT03235271 is an observational study that tracks outcomes without assigning an intervention. The registered 252 participants enrollment target is mid-sized for trials with a published cap, below the 620-participant average among 25 other Stroke, Acute trials with a reported enrollment target (59% lower).
The record links to 1 condition, with Stroke, Acute appearing as the primary indexed condition, and to 1 intervention - of which BrainPulse Device is the first listed.
NCT03235271 reports a single indexed study location in Illinois, Ohio.
Frequently Asked Questions
What is clinical trial NCT03235271 about?
NCT03235271 is a clinical study titled "Pilot Study of Acute Stroke Using the Brainpulse™". The aim of this pilot study is to collect data on stroke patients and non-stroke patients or healthy volunteers using the BrainPulse Stroke Monitor. Subject characteristics, diagnostic procedures and clinical outcomes will be documented as part of the data collected to assess the clinical utility of...
What is the current status of trial NCT03235271?
This trial is currently completed. The enrollment target is 252 participants. The study started on 2017-09-10. Estimated completion is 2024-08-28.
What conditions does trial NCT03235271 study?
This clinical trial studies the following conditions: Stroke, Acute.
What interventions are being tested in trial NCT03235271?
The interventions under investigation include: BrainPulse Device (DEVICE).
Who is sponsoring clinical trial NCT03235271?
This trial is sponsored by Jan Medical, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03235271 being conducted?
This trial has 3 study locations across Illinois, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke, Acute
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03235271's enrollment target sits among peer trials
252 10th of 25 higher than 16 of 25 other Stroke, Acute trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke, Acute trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Somatic Dysfunction in Patients With Acute Cerebrovascular Disease
RECRUITING
-
WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)
RECRUITING · NA
-
Focused Intensive Repeated Stepping During Inpatient Rehabilitation Poststroke - A Quality Improvement Project
RECRUITING
-
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
RECRUITING · NA
-
Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
RECRUITING · NA
-
Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02314988 · 252 participants · Phase 2
Tranexamic Acid to Reduce Blood Loss in Spine Surgery
- NCT03941756 · 252 participants · NA
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
- NCT05219617 · 252 participants · Phase 3
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- NCT05384158 · 252 participants · NA
Valuation in Depressed Mood, Anhedonia, and Anxiety
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI